Intravenous Equipment Market Size, Share, Growth, and Industry Analysis, By Type (Infusion Pump, Catheter, Blood Administration Set, Securement Device, Needleless Connector), By Application (Hospitals & Clinics, Homecare, Ambulatory Care Center), Regional Insights and Forecast to 2035

Intravenous Equipment Market Overview

The global Intravenous Equipment Market size estimated at USD 23366.77 million in 2026 and is projected to reach USD 40146.02 million by 2035, growing at a CAGR of 6.2% from 2026 to 2035.

The Intravenous Equipment Market includes infusion pumps, catheters, administration sets, securement devices, needleless connectors, cannulas, tubing, filters, and accessories used for direct venous delivery of fluids, medicines, blood products, nutrition, and biologics. IV therapy remains central to acute care because hospitals use intravenous access for surgery, emergency medicine, oncology, intensive care, hydration, anesthesia, infection treatment, and parenteral nutrition. IV catheters led the IV therapy devices product mix with 37.78% share in 2025, while hospitals held 48.62% end-user share in the same year. Medication administration represented 43.92% application share in 2025, showing that routine drug delivery remains the core demand base for the Intravenous Equipment Market.

The Intravenous Equipment Market is also shaped by patient-safety expectations because infusion pumps and vascular-access devices directly affect dosing accuracy, bloodstream infection prevention, and line stability. FDA data show approximately 56,000 infusion-pump adverse-event reports from 2005 through 2009 and 87 infusion-pump recalls during the same review period, which increased attention on safer pump software, alarms, connectors, and human-factor design. Needleless connectors and securement devices are gaining importance as hospitals reduce needlestick exposure, accidental dislodgement, and central-line complications. AHRQ states that central line-associated bloodstream infections can cause as many as 28,000 deaths annually in U.S. intensive care units, keeping infection-control products commercially important.

The USA Intravenous Equipment Market is supported by advanced hospital infrastructure, large surgical volumes, home infusion adoption, oncology care, and chronic-disease treatment. The United States holds the largest share of the infusion pumps market within North America, while North America is projected to account for 40.1% of global infusion-pump demand in 2026. U.S. hospitals continue to prioritize smart pumps, safety-engineered catheters, and closed IV systems because medication administration, hydration, chemotherapy, and antibiotics require precise delivery across emergency departments, intensive care units, outpatient clinics, and ambulatory infusion centers.

The USA market also shows strong vulnerability to IV fluid and supply-chain disruptions. In 2024, Hurricane Helene disrupted Baxter’s Marion, North Carolina plant, which supplied 60% of U.S. IV fluids and peritoneal dialysis solutions and produced 1.5 million bags daily. Baxter later planned to import 18,000 tons of IV products using approximately 200 Boeing 747 aircraft, while B. Braun announced a 20% increase in saline-fluid production and more than 30 million additional IV sets.

Key Findings

• Key Market Driver: Hospitals increased IV device adoption as medication administration held 43.92% application share in 2025 across global therapy settings.
• Major Market Restraint: Safety concerns restrained pump replacement as FDA recorded 56,000 adverse-event reports before stronger infusion-pump controls emerged globally.
• Emerging Trends: Home infusion demand expanded as rural patients represented 13.1% of studied home infusion users across 545,280 patients.
• Regional Leadership: North America led infusion-pump demand as the region accounted for 40.1% projected global share in 2026.
• Competitive Landscape: Leading manufacturers strengthened device portfolios as top suppliers supported 60% U.S. IV fluid dependency during disruption.
• Market Segmentation: IV catheters dominated product segmentation as the category recorded 37.78% market share in 2025 globally.
• Recent Development: B. Braun expanded IV fluid production as U.S. saline output increased 20% after the 2024 shortage.

Intravenous Equipment Market Latest Trends

The Intravenous Equipment Market is moving toward smart infusion pumps, safety-engineered catheters, closed connectors, and digitally supported medication delivery. Smart pumps are gaining preference because hospitals need drug libraries, dose-error reduction software, pressure alarms, occlusion alerts, and electronic medical record integration. FDA safety guidance emphasizes improved pump quality because infusion-pump malfunctions have historically produced recalls and adverse events. Catheter innovation is also increasing because IV catheters represented 37.78% product share in 2025, making vascular access the largest equipment base in the IV therapy devices market.

Home infusion and ambulatory infusion are another major trend because patients increasingly receive antibiotics, immunoglobulins, nutrition, and specialty drugs outside inpatient settings. CMS defines home infusion as intravenous or subcutaneous administration of drugs or biologicals at home, requiring equipment such as pumps and supplies such as tubing and catheters. A study of 200 pharmacy locations covered 545,280 unique home infusion patients over 3 years, including 71,278 rural patients, showing that non-hospital therapy settings require reliable portable pumps, connectors, dressing kits, and securement devices.

Intravenous Equipment Market Dynamics

DRIVER

"Rising clinical dependence on IV therapy across hospitals, oncology centers, emergency departments, and homecare."

The Intravenous Equipment Market grows because IV therapy supports fast drug action, fluid correction, nutrition delivery, blood administration, and critical-care treatment. Hospitals held 48.62% end-user share in 2025, confirming inpatient facilities as the largest demand center for IV pumps, catheters, administration sets, connectors, and securement products. Chronic-disease treatment also increases IV use because oncology, infection therapy, renal care, surgery, and intensive care depend on controlled infusion. Medication administration held 43.92% application share in 2025, showing the central role of IV equipment in routine drug delivery. Home infusion further supports growth because CMS lists pumps, tubing, catheters, and nursing services as required components of home infusion therapy.

RESTRAINT

"Safety concerns and device recalls increase compliance pressure across infusion equipment purchasing."

The Intravenous Equipment Market faces restraint from safety incidents, dosing errors, alarm failures, catheter-related infections, and recall management. FDA recorded approximately 56,000 adverse-event reports linked with infusion pumps and 87 infusion-pump recalls during its 2005 review period, making pump reliability a major purchasing requirement. In 2025, FDA identified a Baxter Novum IQ infusion pump correction as the most serious recall type, warning that continued uncorrected use could cause serious injury or death. Infection risk also restrains usage because AHRQ links CLABSI with as many as 28,000 annual deaths in U.S. intensive care units.

OPPORTUNITY

"Home infusion and ambulatory care expansion creates demand for portable, connected, and safer IV systems."

The Intravenous Equipment Market has strong opportunity in homecare and ambulatory infusion because treatment is shifting beyond inpatient wards. CMS states that home infusion therapy requires pumps, tubing, catheters, drugs, supplies, and nursing education for safe administration at home. A multi-center home infusion study counted 545,280 unique patients across 200 pharmacy locations during 3 years, including 71,278 rural patients, creating demand for portable pumps, easy-to-use connectors, securement devices, and standardized administration kits. Ambulatory care centers also need IV equipment for chemotherapy, biologics, hydration, antibiotics, and pain management. Hospitals led end-user share at 48.62% in 2025, leaving homecare and ambulatory channels as practical expansion areas.

CHALLENGE

"Supply-chain concentration and infection-control requirements challenge consistent IV equipment availability."

The Intravenous Equipment Market faces supply-chain challenges because IV fluids, tubing, connectors, pumps, and administration sets depend on concentrated manufacturing capacity and regulated quality systems. In 2024, Baxter’s Marion facility disruption affected a site producing 60% of U.S. IV fluids and peritoneal dialysis solutions, with output of 1.5 million bags daily. The same shortage forced import planning for 18,000 tons of IV products and approximately 200 Boeing 747 aircraft shipments. Infection control adds another challenge because CLABSI prevention requires correct line insertion, maintenance, connector disinfection, securement, and removal protocols. AHRQ reports that CLABSI can cause 28,000 annual deaths in U.S. intensive care units.

Intravenous Equipment Market Segmentation

The Intravenous Equipment Market segments by type into infusion pumps, catheters, blood administration sets, securement devices, and needleless connectors. It segments by application into hospitals and clinics, homecare, and ambulatory care centers. IV catheters led product demand with 37.78% share in 2025, while hospitals led end use with 48.62% share.

BY TYPE

Infusion Pump: Infusion pumps hold an estimated 24% type share because hospitals, oncology centers, intensive-care units, and homecare providers need accurate controlled delivery for antibiotics, chemotherapy, parenteral nutrition, analgesics, and biologics. FDA records show 56,000 historical adverse-event reports and 87 recalls, so buyers increasingly prefer smart pumps with alarms, dose-error reduction, and drug libraries. The segment benefits from home infusion because CMS identifies pumps as required equipment for home administration.

Catheter: Catheters hold 37.78% share, making them the leading product category in the Intravenous Equipment Market in 2025. Demand comes from peripheral IV access, central venous access, peripherally inserted central catheters, oncology infusion, emergency hydration, antibiotic therapy, and blood sampling. Hospitals use catheters daily because medication administration held 43.92% application share in 2025. Catheter suppliers compete on safety features, antimicrobial materials, insertion success, dwell time, kink resistance, and compatibility with closed connectors.

Blood Administration Set: Blood administration sets hold an estimated 12% type share because transfusion support remains essential in surgery, trauma care, oncology, obstetrics, hematology, and intensive care. These sets require filters, drip chambers, tubing, spikes, clamps, and standardized compatibility with blood bags and IV access devices. Hospitals and clinics drive most demand because they held 48.62% end-user share in 2025. Product selection depends on hemolysis prevention, flow consistency, sterility assurance, and compliance with transfusion protocols across acute-care facilities.

Securement Device: Securement devices hold an estimated 9% type share because hospitals use them to reduce catheter movement, accidental dislodgement, dressing disruption, and line complications. Their importance rises in intensive care, pediatrics, oncology, emergency departments, and home infusion where patient movement can compromise IV access. AHRQ links central-line bloodstream infections with as many as 28,000 annual deaths in U.S. intensive care units, increasing demand for securement systems that support line stability and maintenance.

Needleless Connector: Needleless connectors hold an estimated 17% type share because hospitals prioritize closed access, needlestick reduction, disinfection control, and compatibility with IV tubing and catheters. These products support medication administration, blood draws, flushing, and intermittent infusion without repeated needle access. Demand aligns with infection-prevention programs because CLABSI remains a major safety target in acute-care hospitals. AHRQ identifies CLABSI as harmful and preventable through structured safety practices, reinforcing adoption of better connectors, caps, and maintenance protocols.

BY APPLICATION

Hospitals & Clinics: Hospitals and clinics hold 48.62% application share because they manage the highest IV therapy volume across surgery, emergency care, intensive care, oncology, infection treatment, hydration, and nutrition. Their demand includes infusion pumps, catheters, administration sets, securement devices, connectors, filters, and IV fluids. Hospitals invest in smart pumps and safety-engineered access products because FDA and AHRQ safety data show meaningful risks from pump malfunction and line infection. Purchasing priorities include sterility, compatibility, alarm reliability, workflow integration, and staff usability.

Homecare: Homecare holds an estimated 19% application share as more patients receive antibiotics, immunoglobulins, nutrition, and biologics outside inpatient settings. CMS defines home infusion therapy as IV or subcutaneous administration of drugs or biologicals at home and identifies pumps, tubing, catheters, supplies, and nursing education as necessary components. A home infusion study covered 545,280 unique patients over 3 years, including 71,278 rural users. Demand favors portable pumps, simplified connectors, securement kits, and caregiver-friendly administration sets.

Ambulatory Care Center: Ambulatory care centers hold an estimated 14% application share because outpatient infusion suites provide chemotherapy, biologics, hydration, antibiotics, pain management, and specialty drug administration. These centers require reliable infusion pumps, catheters, blood administration sets, connectors, and securement devices for repeat patient visits. Medication administration held 43.92% application share in 2025, supporting ambulatory demand for standardized IV workflows. Growth also comes from hospital capacity pressure, shorter patient stays, and preference for non-inpatient infusion when clinical monitoring remains available.

Intravenous Equipment Market Regional Outlook

The Intravenous Equipment Market shows different growth patterns across regions because healthcare infrastructure, hospital capacity, medical technology adoption, and patient care models influence demand. Developed regions focus on smart infusion systems, infection prevention technologies, and digital healthcare integration, while developing regions emphasize expanding hospital networks, improving emergency care, and increasing access to intravenous therapies. North America, Europe, Asia-Pacific, and the Middle East & Africa represent important markets supported by rising healthcare requirements and increasing use of intravenous treatment methods.

NORTH AMERICA

North America represents a highly developed intravenous equipment market supported by advanced healthcare facilities, strong adoption of infusion technologies, and established patient safety practices. The region uses intravenous equipment extensively across hospitals, intensive care units, emergency departments, oncology centers, and outpatient infusion facilities. The United States remains a major contributor because of its large healthcare system, high number of surgical procedures, and increasing demand for chronic disease management solutions. Hospitals increasingly adopt smart infusion pumps, safety-engineered catheters, needleless connectors, and advanced securement devices to improve medication accuracy and reduce complications. The region also experiences growing demand for home infusion equipment as patients receive more treatments outside hospitals. Healthcare providers continue focusing on infection prevention, electronic health record integration, and reliable intravenous supply systems.

EUROPE

Europe maintains a significant position in the Intravenous Equipment Market due to advanced healthcare infrastructure, aging populations, and strong medical device standards. Countries including Germany, France, the United Kingdom, Italy, and Spain demonstrate high adoption of infusion pumps, vascular access devices, and safety-focused intravenous products. Hospitals across Europe increasingly use smart infusion technologies to improve medication management and reduce administration errors. Rising demand for cancer therapies, antibiotics, biologics, and nutritional support continues supporting intravenous equipment usage. The region also emphasizes infection control because preventing catheter-related complications remains a major healthcare priority. Manufacturers focus on developing efficient infusion systems, environmentally responsible products, and digitally connected devices that support modern healthcare workflows. Government healthcare programs and hospital modernization initiatives continue creating opportunities for intravenous equipment suppliers.

ASIA-PACIFIC

Asia-Pacific represents an expanding Intravenous Equipment Market because healthcare infrastructure development, population growth, and increasing medical treatment requirements continue driving demand. Countries such as China, India, Japan, South Korea, and Australia are improving hospital capacity and adopting advanced medical technologies. Rising cases of chronic diseases, including cancer, diabetes, and cardiovascular disorders, increase the need for infusion therapies, vascular access products, and medication delivery systems. Hospitals in developing economies are investing in modern intensive care units, emergency departments, and specialty treatment centers that require reliable intravenous equipment. The region also benefits from increasing local manufacturing capabilities, which improve product availability and support healthcare expansion. Growing acceptance of home healthcare and ambulatory treatment models creates additional demand for portable infusion systems and easy-to-use intravenous devices.

MIDDLE EAST & AFRICA

The Middle East & Africa Intravenous Equipment Market is developing through healthcare infrastructure expansion, hospital construction, and improved access to medical services. Countries including Saudi Arabia, the United Arab Emirates, South Africa, and Egypt are increasing investments in healthcare facilities and advanced treatment centers. Intravenous equipment demand is rising because hospitals require infusion pumps, catheters, administration sets, and securement devices for emergency care, surgery, oncology, and critical care applications. Regional healthcare providers are adopting international safety standards and improving infection-control practices. Medical tourism growth in selected Middle Eastern countries also supports demand for advanced hospital technologies. Challenges such as healthcare access differences and limited infrastructure in some areas continue affecting adoption, but government healthcare initiatives and private-sector investments are strengthening market opportunities.

List of Top Intravenous Equipment Companies

• Becton Dickinson and Company
• Baxter International
• Fresenius SE
• ICU Medical
• Smiths Medical
• Moog
• Terumo Corporation
• AngioDynamics

List of Top 2 Companies Market Share

• Becton Dickinson and Company: The company maintains a strong position in the Intravenous Equipment Market through its broad portfolio of vascular access devices, infusion products, and medication management solutions used across hospitals and healthcare facilities worldwide.
• Baxter International: The company remains a major participant in intravenous therapy through its infusion systems, intravenous solutions, administration products, and hospital-focused technologies supporting medication delivery and patient care.

Investment Analysis and Opportunities

Investment opportunities in the Intravenous Equipment Market are increasing as healthcare providers focus on safer medication delivery, digital healthcare solutions, and patient-centered treatment models. Hospitals are investing in smart infusion pumps, automated medication systems, advanced vascular access devices, and technologies that improve clinical workflow. The expansion of home healthcare creates opportunities for portable infusion equipment, lightweight pumps, and simplified administration systems that allow patients to receive treatment outside traditional hospitals. Increasing demand for oncology therapies, biologic medicines, and specialty drugs continues supporting innovation in intravenous delivery technologies.

Manufacturers are also focusing on improving device connectivity, cybersecurity, user-friendly interfaces, and integration with hospital information systems. Emerging healthcare markets provide additional opportunities because governments are expanding hospitals, improving emergency care facilities, and increasing access to advanced medical treatments. Companies investing in infection-control technologies, safety-engineered devices, and sustainable manufacturing processes can strengthen their position in the competitive intravenous equipment industry. Research and development activities remain focused on improving patient safety, reducing complications, and increasing efficiency throughout intravenous therapy workflows.

New Product Development

New product development in the Intravenous Equipment Market focuses on improving accuracy, safety, connectivity, and ease of use. Manufacturers are developing smart infusion pumps with advanced monitoring features, automated alerts, digital connectivity, and improved medication management capabilities. These systems help healthcare professionals deliver medicines with greater precision while reducing manual errors. Vascular access device innovation includes antimicrobial materials, improved catheter designs, advanced securement methods, and products designed to support longer treatment periods.

Companies are also developing portable and wearable infusion technologies to support homecare and ambulatory treatment environments. Needleless connectors, closed infusion systems, and advanced administration sets are being improved to support infection prevention and safer handling. Digital healthcare integration is becoming an important development area as hospitals require devices that communicate with electronic medical records and clinical information systems. Future innovations are expected to focus on artificial intelligence support, remote monitoring capabilities, and environmentally responsible device designs that improve healthcare efficiency.

Five Recent Developments

• Major manufacturers expanded smart infusion pump technologies with improved connectivity, medication safety features, and hospital information system integration.
• Healthcare companies increased focus on home infusion solutions by developing portable pumps and patient-friendly intravenous delivery devices.
• Medical device manufacturers introduced improved vascular access products designed to support infection prevention and catheter stability.
• Infusion technology companies enhanced cybersecurity features to protect connected medical devices used in hospital environments.
• Manufacturers increased research activities in digital infusion management systems to improve treatment monitoring and clinical efficiency.

Report Coverage of Intravenous Equipment Market

The Intravenous Equipment Market report covers major product categories including infusion pumps, intravenous catheters, blood administration sets, securement devices, needleless connectors, and related accessories. The report analyzes market trends, technology advancements, healthcare applications, regional developments, competitive landscape, and investment opportunities. It evaluates how hospitals, clinics, homecare providers, and ambulatory care centers use intravenous equipment for medication delivery, fluid management, blood transfusion, nutritional support, and critical care treatment.

The report also examines important factors influencing market development, including rising healthcare demand, increasing chronic disease treatment requirements, patient safety initiatives, digital healthcare adoption, and improvements in vascular access technology. It provides insights into product innovation, healthcare infrastructure development, manufacturer strategies, and changing treatment approaches. The coverage highlights opportunities created by home infusion growth, smart medical devices, and expanding healthcare access in emerging regions. The report supports understanding of the global intravenous equipment industry by analyzing key segments, regional performance, technological changes, and future development areas.